Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells

Endocrinology

Volumn 144, Issue 8, 2003, Pages 3306-3314

  Shepherd, Trevor G ^a   Nachtigal, Mark W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR; OSTEOGENIC PROTEIN 1; SMAD PROTEIN; SMAD4 PROTEIN;

ARTICLE; AUTOCRINE EFFECT; CELL ADHESION; CELL SPREADING; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

BIOLOGICAL TRANSPORT; BONE MORPHOGENETIC PROTEINS; CELL NUCLEUS; DNA-BINDING PROTEINS; EPITHELIUM; FEMALE; HUMANS; OVARIAN NEOPLASMS; OVARY; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMAD1 PROTEIN; TRANS-ACTIVATORS;

EID: 0041314104     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0185     Document Type: Article

References (42)

1. Balemans W, Van Hul W 2002 Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250:231-250
2. Shimasaki S, Zachow RJ, Li D, Kim H, Iemura S, Ueno N, Sampath K, Chang RJ, Erickson GF 1999 A functional bone morphogenetic protein system in the oval. Proc Natl Acad Sci USA 96:7282-7287
3. Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, Carino C, Prasad SV, Skinner SS, Dunbar BS, Dube JL, Celeste AJ, Matzuk MM 2001 Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 15:854-866
4. Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW, Beattie AE, Davis GH, Ritvos O 2000 Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 25:279-283
5. Wilson T, Wu XY, Juengel JL, Ross IK, Lumsden JM, Lord EA, Dodds KG, Walling GA, McEwan JC, O'Connell AR, McNatty KP, Montgomery GW 2001 Highly prolific Booroola sheep have a mutation in the intracellular kinase domain of bone morphogenetic protein IB receptor (ALK-6) that is expressed in both oocytes and granulosa cells. Biol Reprod 64:1225-1235
6. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC 2001 Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22:255-288
7. Yamada N, Kato M, ten Dijke P, Yamashita H, Sampath TK, Heldin CH, Miyazono K, Funa K 1996 Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma hamours. Br J Cancer 73:624-629
8. Ide H, Yoshida T, Matsumoto N, Aoki K, Osada Y, Sugimura T, Terada M 1997 Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res 57:5022-5027
9. Soda H, Raymond E, Sharma S, Lawrence R, Cerna C, Gomez L, Timony GA, Von Hoff DD, Izbicka E 1998 Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units. Anti-cancer Drugs 9:327-331
10. Kawamura C, Kizaki M, Yamato K, Uchida H, Fukuchi Y, Hattori Y, Koseki T, Nishihara T, Ikeda Y 2000 Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood 96:2005-2011
11. Hjertner O, Hjorth-Hansen H, Borset M, Seidel C, Waage A, Sundan A 2001 Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood 97:516-522
12. Wach S, Schirmacher P, Protschka M, Blessing M 2001 Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members. Oncogene 20:7761-7769
13. Hamdy FC, Autzen P, Robinson MC, Horne CH, Neal DE, Robson CN 1997 Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue. Cancer Res 57:4427-4431
14. Autzen P, Robson CN, Bjartell A, Malcolm AJ, Johnson MI, Neal DE, Hamdy FC 1998 Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. Br J Cancer 78:1219-1223
15. Kim IY, Lee DH, Ahn HJ, Tokunaga H, Song W, Devereaux LM, Jin D, Sampath TK, Morton RA 2000 Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates -with tumor grade in human prostate cancer tissues. Cancer Res 60:2840-2844
16. Jin Y, Tipoe GL, Liong EC, Lau TY, Fung PC, Leung KM 2001 Overexpression of BMP-2/4, -5 and BMPR-IA associated with malignancy of oral epithelium. Oral Oncol 37:225-233
17. Norton JD 2000 ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 113:3897-3905
18. Dunfield LD, Campbell Dwyer EJ, Nachtigal MW 2002 TGF β-induced Smad signaling remains intact in primary human ovarian cancer cells. Endocrinology 143:1174-1181
19. Dunfield LD, Shepherd TG, Nachtigal MW 2002 Primary culture and mRNA analysis of human ovarian cells. Biol Proc Online 4:55-61
20. Ishida W, Hamamoto T, Kusanagi K, Yagi K, Kawabata M, Takehara K, Sampath TK, Kato M, Miyazono K 2000 Smad6 is a Smadl/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem 275:6075-6079
21. Koenig BB, Cook JS, Wolsing DH, Ting J, Tiesman JP, Correa PE, Olson CA, Pecquet AL, Ventura F, Grant RA, Chert G-X, Wrana JL, Massague J, Rosenbaum JS 1994 Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 14:5961-5974
22. Kretzschmar M, Liu F, Hata A, Doody J, Massague J 1997 The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 11:984-985
23. Afrakhte M, Moren A, Jossan S, Itoh S, Sampath K, Westermark B, Heldin CH, Heldin NE, ten Dijke P 1998 Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem Biophys Res Commun 249:505-511
24. Ghosh-Choudhury N, Ghosh-Choudhury G, Celeste A, Ghosh PM, Moyer M, Abboud SL, Kreisberg J 2000 Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Biochim Biophys Acta 1497:186-196
25. Kruk PA, Uitto VJ, Firth JD, Dedhar S, Auersperg N 1994 Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp Cell Res 215:97-108
26. Cruet S, Salamanca C, Mitchell GW, Auersperg N 1999 αvβ3 and vitronectin expression by normal ovarian surface epithelial cells: role in cell adhesion and cell proliferation. Gynecol Oncol 75:254-260
27. Cannistra SA, Ottensmeier C, Niloff J, Orta B, DiCarlo J 1995 Expression and function of β 1 and α β 3 integrins in ovarian cancer. Gynecol Oncol 58:216-225
28. Strobel T, Cannistra SA 1999 β1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol 73:362-367
29. Hapke S, Kessler H, Arroyo de Prada N, Benge A, Schmitt M, Lengyel E, Reuning U 2001 Integrin α(v)β(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells. J Biol Chem 276:26340-26348
30. Carreiras F, Cruet S, Staedel C, Sichel F, Gauduchon P 1999 Human ovarian adenocarcinoma cells synthesize vitronectin and use it to organize their adhesion. Gynecol Oncol 72:312-322
31. Heikinheimo KA, Laine MA, Ritvos OV, Voutilainen RJ, Hogan BL, Leivo IV, Heikinhelmo AK 1999 Bone morphogenetic protein-6 is a marker of serous acinar cell differentiation in normal and neoplastic human salivary gland. Cancer Res 59:5815-5821
32. Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Petersen GM, Velculescu VE, Traverso G, Vogelstein B 2001 Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28:184-187
33. Nissinen L, Pirila L, Heino J 1997 Bone morphogenetic protein-2 is a regulator of cell adhesion. Exp Cell Res 230:377-385
34. Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A 1999 Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 274:19838-19845
35. Clement JH, Marr N, Meissner A, Schwalbe M, Sebald W, Kliche KO, Hoffken K, Wolff S 2000 Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol 126:271-279
36. Desprez P-Y, Lin CQ, Thomasset N, Sympson CJ, Bissell MJ, Campisi J 1998 A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol Cell Biol 18:4577-4588
37. Norton JD, Atherton GT 1998 Coupling of cell growth control and apoptosis functions of Id proteins. Mol Cell Biol 18:2371-2381
38. Wice BM, Gordon JI 1998 Forced expression of Id-1 in the adult mouse small intestinal epithelium is associated with development of adenomas. J Biol Chem 273:25310-25319
39. Kleeff J, Ishiwata T, Friess H, Buchler MW, Israel MA, Korc M 1998 The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer. Cancer Res 58:3769-3772
40. Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J, Desprez P-Y 2000 A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res 60:1332-1340
41. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P 2001 Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res 61:5703-5706
42. Schindl M, Schoppmann SF, Ströbel T, Heinzl H, Leisser C, Horvat R, Birner P 2003 Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res 9:779-785